Jane Doe v. Torrance Memorial Medical Center

CourtDistrict Court, C.D. California
DecidedApril 12, 2023
Docket2:23-cv-01237
StatusUnknown

This text of Jane Doe v. Torrance Memorial Medical Center (Jane Doe v. Torrance Memorial Medical Center) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jane Doe v. Torrance Memorial Medical Center, (C.D. Cal. 2023).

Opinion

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA

JANE DOE, individually and on CV 23-01237 DSF (JPRx) behalf of others similarly situated, Plaintiff, Order GRANTING Motion to Remand (Dkt. 30) v.

TORRANCE MEMORIAL MEDICAL CENTER, Defendant.

Plaintiff Jane Doe moves to remand this action to the Superior Court of California, County of Los Angeles. Dkt. 30 (Mot.). Defendant Torrance Memorial Medical Center (Torrance) opposes. Dkt. 40 (Opp’n). The Court deems this matter appropriate for decision without oral argument. See Fed. R. Civ. P. 78; Local Rule 7-15. I. BACKGROUND On January 1, 2023, Plaintiff Jane Doe filed a class action lawsuit in California Superior Court on behalf of herself and all other similarly situated California citizens who had their highly sensitive personal information disclosed to Facebook without their knowledge or consent. See Dkt. 1-1, Ex. A at 3 (Compl.). Doe alleges that Torrance promises patients and prospective patients that it will not disclose their Health Information for marketing purposes without their written authorization, but contrary to these assurances, Torrance does not “follow the law prohibiting such disclosures.” Id. ¶ 2. Doe alleges that since at least 2017, Torrance has disclosed protected health information to Facebook and other third parties without patients’ knowledge authorization, or consent. Id. ¶ 3. Torrance has deployed “various digital marketing and automatic rerouting tools embedded on its websites that purposefully and intentionally redirect personal health information to Facebook, who exploits that information for advertising purposes.” Id. ¶ 4. On February 17, 2023, Torrance removed the case pursuant to 28 U.S.C. § 1442(a)(1), the federal officer removal statute. See Dkt. 1. II. LEGAL STANDARD A defendant may remove to federal court a state court action brought against the “United States or any agency thereof or any officer (or any person acting under that officer) of the United States or of any agency thereof, sued in an official or individual capacity for any act under color of such office . . . .” 28 U.S.C. § 1442(a)(1); Watson v. Philip Morris Cos., Inc., 551 U.S. 142, 145 (2007). Federal officer removal is available under 28 U.S.C. § 1442(a) if “(a) [the removing party] is a ‘person’ within the meaning of the statute; (b) there is a causal nexus between its actions, taken pursuant to a federal officer’s directions, and plaintiff’s claims; and (c) it can assert a ‘colorable federal defense.’” Fidelitad, Inc. v. Insitu, Inc., 904 F.3d 1095, 1099 (9th Cir. 2018). III. DISCUSSION Torrance asserts that “[o]ver the past two decades, the federal government has engaged in an extensive effort to build a nationwide health information technology infrastructure,” and this case challenges the legitimacy of actions Torrance “has taken in connection with pursuing that directive.” Dkt. 1 at 1. Torrance contends that it has dutifully assisted and followed the federal government’s direction in a public-private initiative to develop a nationwide infrastructure for health information technology, and in doing so, “has acted within the penumbra of federal action and office.” Id. at 4. Torrance argues that it qualifies as a “person” under the statute and effectively acted under a federal officer. Id. at 6-8. Torrance explains that the Office of the National Health Coordinator for Health Information Technology (ONC) published guidance for private providers to follow, including a five-year strategic plan that dictated that federal agencies were to collaborate with private stakeholders to build a culture of electronic health information access and use. Id. at 5. One aspect of the strategy was the Centers for Medicare & Medicaid Services’ (CMS) Meaningful Use Program (MUP), aimed at increasing patients’ meaningful use and engagement with electronic health records through the creation of patient portals. Id. According to Torrance, under the program, “providers must meet certain criteria to receive full Medicare reimbursement, one of which is having an interoperable patient portal.” Id. Torrance asserts that it acted under a federal officer because the federal government incentivizes, regulates, monitors, and supervises Torrance’s actions as part of the MUP “in order to meet the government’s national priority of interoperable health information technology,” and Torrance is helping the government produce the “nationwide, interoperable information technology infrastructure for health information.” Id. at 7. Torrance contends that in the absence of its actions, the government “would be left alone to complete its mission,” that the government has specified how to best enhance patient engagement, including through a patient portal, and that the government has created an office dedicated to this issue and has closely monitored the work of private entities like Torrance. Id. at 8. Doe asks the Court to reject Torrance’s attempt to expand the federal officer removal statute. She argues that Torrance is not effectively acting under a federal officer and is not acting on behalf of a federal officer in a manner akin to an agency relationship. Id. at 9-11. She contends that providing patient records is a private function, not a governmental task, and mere regulation or incentive through the MUP cannot turn a private hospital into an entity acting under a federal officer. Id. at 10 (citing Watson, 551 U.S. at 153). Doe also argues: (1) the MUP is a prototypical regulatory program that cannot create federal officer jurisdiction, (2) federal officer jurisdiction is improper because keeping private medical records is not a basic governmental task, (3) no “significant risk of state-court prejudice” exists, and (4) Torrance relies only on out-of-circuit outlier decisions that have been firmly rejected by other courts. Id. at 13-20. Torrance asserts in opposition that it assisted the federal government in carrying out a federal directive by increasing web traffic to its website, which contains a link to a patient portal. Opp’n at 7. It asserts that its “alleged efforts were in furtherance of implementing the federal government’s goal” and are sufficient to effectuate removal to this Court. Id. Torrance also asserts that it gave patients the opportunity to access their personal electronic health records with Torrance through a MyTorranceMemorial patient portal and submitted reports on its involvement in the MUP to CMS. Id. at 12. The Court agrees with Doe. The Supreme Court has “interpreted the term ‘person acting under that officer’ as extending to a ‘private person’ who has certain types of close relationships with the federal government.” Cnty. of San Mateo, 32 F.4th at 756 (citing Watson, 551 U.S. at 152-53). “The Supreme Court has identified a number of factors courts should consider in determining whether a private person is acting under a federal officer for purposes of § 1442(a)(1).” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Watson v. Philip Morris Companies, Inc.
551 U.S. 142 (Supreme Court, 2007)
Fidelitad, Inc. v. Insitu, Inc.
904 F.3d 1095 (Ninth Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Jane Doe v. Torrance Memorial Medical Center, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jane-doe-v-torrance-memorial-medical-center-cacd-2023.